학술논문

Coenzyme Q10 trapping in mitochondrial complex I underlies Lebers hereditary optic neuropathy.
Document Type
article
Source
Proceedings of the National Academy of Sciences of USA. 120(39)
Subject
Coenzyme Q10
blinding genetic disease
mitochondria
molecular dynamics simulation
quantum electron tunneling
Humans
Optic Atrophy
Hereditary
Leber
Reactive Oxygen Species
Electron Transport Complex I
Alanine
Language
Abstract
How does a single amino acid mutation occurring in the blinding disease, Lebers hereditary optic neuropathy (LHON), impair electron shuttling in mitochondria? We investigated changes induced by the m.3460 G>A mutation in mitochondrial protein ND1 using the tools of Molecular Dynamics and Free Energy Perturbation simulations, with the goal of determining the mechanism by which this mutation affects mitochondrial function. A recent analysis suggested that the mutations replacement of alanine A52 with a threonine perturbs the stability of a region where binding of the electron shuttling protein, Coenzyme Q10, occurs. We found two functionally opposing changes involving the role of Coenzyme Q10. The first showed that quantum electron transfer from the terminal Fe/S complex, N2, to the Coenzyme Q10 headgroup, docked in its binding pocket, is enhanced. However, this positive adjustment is overshadowed by our finding that the mobility of Coenzyme Q10 in its oxidized and reduced states, entering and exiting its binding pocket, is disrupted by the mutation in a manner that leads to conditions promoting the generation of reactive oxygen species. An increase in reactive oxygen species caused by the LHON mutation has been proposed to be responsible for this optic neuropathy.